GADD45B Human

Growth Arrest and DNA-Damage-Inducible Beta Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to GADD45B

GADD45B belongs to the GADD45 family of small (18 kDa) nuclear proteins that regulate cell cycle arrest, DNA repair, and apoptosis under stress conditions . It is activated by diverse stimuli, including oxidative stress, cytokine exposure, and genotoxic agents . Its aliases include MYD118 and GADD45BETA .

Molecular Functions and Mechanisms

DNA Demethylation and Epigenetic Regulation
GADD45B facilitates activity-dependent DNA demethylation at specific gene promoters (e.g., BDNF, FGF1) through base excision repair (BER) mechanisms, enabling neurogenesis and synaptic plasticity . This demethylation is critical for adult brain function, influencing memory formation and stress responses .

Stress Response Pathways

  • Activates p38/JNK MAPK pathways by binding upstream kinases like MTK1/MEKK4 .

  • Protects retinal ganglion cells (RGCs) from oxidative stress, TNFα cytotoxicity, and glutamate excitotoxicity .

  • Modulates apoptosis via interactions with ASK1 and MAP3K4, balancing cell survival and death .

Protein Interactions

Interacting PartnerFunctional Role
ASK1Apoptosis regulation
MAP3K4Stress signaling activation
GADD45GIP1Cell cycle control
MAP2K7JNK pathway modulation
Table 1: Key protein interactions of GADD45B .

Role in Neurological and Neuropsychiatric Disorders

Neuroprotection and Plasticity

  • GADD45B knockout mice exhibit impaired neurogenesis and synaptic plasticity due to hypermethylation of BDNF and FGF1 promoters .

  • Upregulated in post-mortem brains of psychotic patients, correlating with antipsychotic drug efficacy .

Clinical Associations

DisorderGADD45B DysregulationOutcome
DepressionReduced activity-induced demethylationImpaired neurogenesis
StrokeEnhanced expression post-injuryNeuroprotection
AutismEpigenetic dysregulationBehavioral deficits
Table 2: Neurological implications of GADD45B .

Implications in Cancer Biology

Tumor Suppression vs. Chemoresistance

  • Prostate Cancer: Downregulated in metastatic prostate cancer (mPCa); overexpression enhances chemosensitivity to docetaxel via p38/MAPK pathway activation .

  • Skin Aging: GADD45B deficiency accelerates senescence via unchecked JNK signaling, promoting tissue aging .

Mechanistic Insights

  • Regulates apoptosis through p38 phosphorylation: Overexpression increases caspase-3 cleavage and PARP activation in cancer cells .

  • Modulates cell cycle checkpoints (G2/M) under genotoxic stress .

Diagnostic and Therapeutic Potential

Biomarker Performance

  • Prostate Cancer: Low GADD45B expression predicts poor prognosis (HR = 1.87, p < 0.01) .

  • Psychosis: Elevated mRNA levels correlate with antipsychotic response (Cohen’s d = 1.2) .

Therapeutic Strategies

ApproachMechanismStatus
Gene therapyLentiviral GADD45B overexpressionPreclinical (PCa models)
Small-molecule activatorsMAPK pathway modulationExperimental
Table 3: Emerging therapeutic avenues .

Research Gaps and Future Directions

  • Clinical Translation: No human trials targeting GADD45B exist despite robust preclinical evidence.

  • Context-Dependent Roles: Dual pro-survival (neurons) and pro-apoptotic (cancer) functions require tissue-specific targeting strategies.

  • Epigenetic Crosstalk: How GADD45B cooperates with other demethylases (e.g., TET enzymes) remains unclear .

Product Specs

Introduction
GADD45B, a nuclear protein, interacts with various proteins whose transcription levels increase in response to stressful growth arrest conditions and DNA-damaging agents. It mediates the activation of the p38/JNK pathway by binding to and activating MTK1/MEKK4 kinase, an upstream activator of both p38 and JNK MAPKs. This process allows GADD45B to respond to environmental stresses. GADD45B plays a role in regulating growth and apoptosis. It participates in chondrocyte terminal differentiation and mediates MMP-13 gene expression. In B cells, CD40 induces GADD45B through an NF-kappa B-dependent mechanism, and this induction suppresses Fas-mediated killing. Downregulation of GADD45B is observed in most hepatocellular carcinoma (HCC) cases, making it a potential molecular marker for HCC diagnosis and a possible therapeutic target.
Description
Recombinant Human GADD45B, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 160 amino acids. It has a molecular weight of 17.8 kDa.
Physical Appearance
Colorless, sterile filtered solution.
Formulation
The GADD45B protein solution is supplied in 20mM Tris-HCl (pH 7.5) and 20% glycerol.
Stability
For short-term storage (2-4 weeks), store at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 95.0% by SDS-PAGE analysis.
Synonyms
MYD118, GADD45BETA, GADD45B, Growth arrest and DNA-damage-inducible protein GADD45 beta, Myeloid differentiation primary response protein MyD118, Negative growth regulatory protein MyD118, DKFZp566B133.
Source
Escherichia Coli.
Amino Acid Sequence
MTLEELVACD NAAQKMQTVT AAVEELLVAA QRQDRLTVGV YESAKLMNVD PDSVVLCLLA IDEEEEDDIA LQIHFTLIQS FCCDNDINIV
RVSGMQRLAQ LLGEPAETQG TTEARDLHCL LVTNPHTDAW KSHGLVEVAS YCEESRGNNQ WVPYISLQER.

Q&A

What is GADD45B and what are its primary functions in human cellular pathways?

GADD45B is a member of the growth arrest and DNA damage-inducible gene family that responds to environmental stressors and DNA damage. Research indicates that GADD45B plays critical roles in:

  • Environmental stress response mechanisms

  • DNA damage signaling pathways

  • Cell cycle regulation, particularly growth arrest

  • Modulation of apoptotic processes

  • DNA methylation/demethylation mechanisms

Methodologically, researchers typically investigate these functions through gene expression studies using quantitative PCR and Western blotting to detect expression changes under various conditions. Functional studies often employ gene knockdown or overexpression approaches followed by phenotypic analysis of cellular processes .

How is GADD45B expression regulated in response to environmental stress conditions?

GADD45B demonstrates significant expression changes in response to various environmental stressors. Studies in prostate cancer cell lines have shown that GADD45B is upregulated when cells are exposed to:

  • Hypoxic conditions

  • Serum deprivation (low serum medium)

  • Chemotherapeutic agents (e.g., docetaxel)

These findings suggest GADD45B serves as a stress-responsive element that becomes activated when cells face adverse environmental conditions. To investigate this regulation, researchers typically establish stress models by culturing cells in hypoxic incubators, low serum medium, or with chemotherapeutic agents, followed by RNA and protein analysis to quantify expression changes .

What experimental approaches are commonly used to detect and measure GADD45B expression?

Several methods have been established for detecting GADD45B:

Protein Detection:

  • Immunohistochemistry (IHC) using GADD45B-specific antibodies (typically 1:100 dilution)

  • Western blotting with GADD45B antibodies (typically 1:500 dilution)

  • Immunoreactivity scoring system (IRS) for quantification

mRNA Detection:

  • Quantitative RT-PCR using GADD45B-specific primers

  • RNA sequencing for transcriptome-wide analysis

For immunohistochemical quantification, researchers typically calculate an immunoreactivity score (IRS) as: IRS = intensity score × percentage score, where intensity is scored 0-3 and percentage of positive cells is scored 1-4. Samples are then classified as having low (IRS ≤ 6) or high (IRS > 6) GADD45B expression .

What role does GADD45B play in chemotherapy resistance in prostate cancer?

GADD45B appears to be integrally involved in mediating chemotherapy resistance in advanced prostate cancer. Research findings indicate:

  • GADD45B expression increases significantly when prostate cancer cells are exposed to docetaxel treatment

  • Low GADD45B expression may promote tolerance to harsh microenvironments and chemotherapy

  • GADD45B influences treatment response through environmental stress adaptation rather than directly affecting proliferation or migration

To study this phenomenon, researchers have employed several methodological approaches:

  • Construction of GADD45B-overexpressing cell lines using lentiviral vectors

  • Environmental stress modeling using hypoxic conditions, low serum, or docetaxel exposure

  • Assessment of cell viability via MTS and colony formation assays

  • Analysis of apoptosis and cell cycle progression using flow cytometry with annexin V–APC, 7-AAD, and propidium iodide staining

  • RNA sequencing to identify downstream pathways affected by GADD45B modulation

How can researchers effectively modulate GADD45B expression in experimental cancer models?

Several established approaches exist for modulating GADD45B expression in research settings:

Overexpression Methods:

  • Lentiviral transfection using vectors such as pLV-CMV-EF-1a-CopGFP-T2A-puro

  • Cloning the GADD45B sequence into expression vectors

  • Selection of stable cell lines following transduction

Knockdown Methods:

  • GADD45B-targeted shRNA constructs

  • Transfection protocols optimized for specific cell types

For verification of successful modulation, researchers typically employ:

  • RT-PCR to confirm changes in mRNA expression

  • Western blotting to validate protein level alterations

  • Functional assays to assess phenotypic consequences of expression changes

How does GADD45B function as a neuroprotective factor in ischemic conditions?

Research indicates that GADD45B plays a significant neuroprotective role in the context of global ischemia:

  • GADD45B is upregulated in response to ischemia-induced neuronal stress

  • Knockdown of GADD45B accelerates neuronal death in hydrogen peroxide-induced oxidative stress models

  • GADD45B appears to modulate mitochondrial dysfunction by influencing levels of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) factors

Experimental approaches used to investigate this function include:

  • Global ischemia animal models

  • Primary neuron cultures subjected to oxidative stress with H₂O₂

  • GADD45B knockdown using shRNA constructs

  • Assessment of cell death through LDH cytotoxicity measurement

  • Analysis of mitochondrial dysfunction markers by Western blotting

What is the relationship between GADD45B and DNA methylation in neuropsychiatric disorders?

Emerging research has identified GADD45B as a potential mediator of DNA methylation changes in psychotic disorders:

  • GADD45B mRNA and protein levels are increased in brain samples from patients with psychosis

  • GADD45B participates in a coordinated DNA demethylation pathway involving cytidine deaminases and thymidine glycosylases

  • In psychotic subjects, there is reduced GADD45B binding to specific gene promoters (e.g., BDNF IXabcd promoter)

  • This altered binding correlates with changes in DNA methylation markers (5-methylcytosine and 5-hydroxymethylcytosine) at target promoters

Research methodology in this area typically includes:

  • Expression analysis in postmortem brain tissue samples

  • Immunohistochemistry to quantify GADD45B-positive cells in specific cortical layers

  • Analysis of GADD45B binding to target gene promoters

  • Quantification of DNA methylation markers at specific genomic loci

What analytical techniques are most effective for investigating GADD45B-related signaling pathways?

Multiple analytical approaches are employed to elucidate GADD45B-related pathways:

Transcriptome Analysis:

  • RNA sequencing followed by differential expression analysis

  • Genes with log2(fold change) ≥1 or ≤−1 are typically considered significantly differentially expressed

  • Bioinformatic analysis includes Gene Ontology (GO) term analysis and Gene Set Enrichment Analysis (GSEA)

Protein Interaction Analysis:

  • Western blotting for key pathway components (e.g., P38, p-p38)

  • Co-immunoprecipitation studies to identify interaction partners

  • Phosphorylation analysis to identify downstream signaling events

Functional Assays:

  • Apoptosis assessment using annexin V–APC and 7-AAD staining with flow cytometric analysis

  • Cell cycle analysis using propidium iodide staining followed by ModFit software analysis

  • Cell viability testing via MTS assay and colony formation assays

How can researchers design experiments to investigate GADD45B's role in DNA damage response?

Effective experimental design for studying GADD45B in DNA damage response includes:

Induction of DNA Damage:

  • Treatment with genotoxic agents (e.g., hydrogen peroxide, docetaxel)

  • Radiation exposure to induce double-strand breaks

  • Hypoxic conditions to trigger stress response pathways

Analysis of GADD45B Response:

  • Time-course analysis of GADD45B expression following damage

  • Subcellular localization studies using immunofluorescence

  • Chromatin immunoprecipitation to identify genomic binding sites

Functional Consequences:

  • Flow cytometry to assess cell cycle arrest and apoptosis

  • Analysis of DNA repair pathway components

  • Assessment of cellular survival and recovery following damage

These approaches should be combined with GADD45B modulation (overexpression or knockdown) to establish causative relationships between GADD45B and specific aspects of the DNA damage response .

How might GADD45B serve as a diagnostic or therapeutic target in cancer?

Research suggests GADD45B has potential as both a diagnostic marker and therapeutic target:

Diagnostic Applications:

  • Expression analysis in tumor biopsies may provide prognostic information

  • GADD45B levels correlate with clinical characteristics in certain cancers

  • Immunohistochemical analysis using standardized scoring systems can stratify patients

Therapeutic Targeting Strategies:

  • Modulation of GADD45B expression to sensitize resistant tumors to chemotherapy

  • Targeting downstream pathways regulated by GADD45B

  • Combination approaches targeting GADD45B-related stress response mechanisms

Methodological considerations for translational research include:

  • Analysis of GADD45B expression in patient samples using IHC or molecular methods

  • Correlation of expression levels with clinical outcomes using appropriate statistical methods

  • Preclinical testing of GADD45B-targeted therapies using cell line and animal models

  • Identification of patient subgroups most likely to benefit from GADD45B-targeted approaches

What challenges exist in translating GADD45B research findings to clinical applications?

Several methodological and conceptual challenges must be addressed:

Technical Challenges:

  • Standardization of detection methods across different laboratories and clinical settings

  • Development of specific modulators of GADD45B activity for therapeutic use

  • Identification of optimal biomarkers for patient selection

Biological Complexities:

  • GADD45B functions differently in various cellular contexts and tissue types

  • Compensatory mechanisms may limit effectiveness of GADD45B-targeted approaches

  • Integration of GADD45B with broader stress response networks needs further elucidation

Clinical Translation Strategies:

  • Development of companion diagnostics for GADD45B-targeted therapies

  • Design of combination approaches targeting multiple stress response pathways

  • Implementation of personalized approaches based on individual tumor characteristics

Product Science Overview

Introduction

Growth Arrest and DNA-Damage-Inducible Beta (GADD45β) is a protein encoded by the GADD45B gene. It belongs to the GADD45 family, which includes GADD45α and GADD45γ. These proteins are involved in cellular responses to stress, including DNA repair, cell cycle arrest, and apoptosis. GADD45β is particularly significant due to its role in mediating cellular responses to environmental stresses and its involvement in various diseases, including cancer and neuropsychiatric disorders .

Biological Function

GADD45β plays a crucial role in maintaining genomic stability. It is involved in the regulation of the cell cycle, particularly in response to DNA damage. When cells experience stress or DNA damage, GADD45β is upregulated, leading to cell cycle arrest and allowing time for DNA repair mechanisms to correct any damage. This function is vital for preventing the propagation of mutations that could lead to cancer .

Mechanism of Action

GADD45β exerts its effects through several pathways. One of the primary mechanisms is the activation of the MAPK (Mitogen-Activated Protein Kinase) pathway. Specifically, GADD45β can activate the p38 MAPK pathway, which is involved in the cellular response to stress. This activation leads to the phosphorylation of various downstream targets, including transcription factors and other proteins involved in cell cycle regulation and apoptosis .

Role in Disease

GADD45β has been implicated in several diseases. In cancer, GADD45β can act as a tumor suppressor by promoting cell cycle arrest and apoptosis in response to DNA damage. However, its role can be context-dependent, as it may also contribute to cancer progression in certain contexts by promoting cell survival under stress conditions .

In neuropsychiatric disorders, GADD45β is involved in the regulation of DNA methylation, a process that affects gene expression. Abnormal DNA methylation patterns have been linked to various mental health conditions, including schizophrenia and bipolar disorder. Studies have shown that GADD45β-mediated DNA demethylation is altered in patients with these disorders, suggesting a potential role in their pathophysiology .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.